Literature DB >> 24657876

Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures.

Daniel H Wolf1, Theodore D Satterthwaite2, Jacob J Kantrowitz2, Natalie Katchmar2, Lillie Vandekar2, Mark A Elliott3, Kosha Ruparel2.   

Abstract

Motivational deficits play a central role in disability caused by schizophrenia and constitute a major unmet therapeutic need. Negative symptoms have previously been linked to hypofunction in ventral striatum (VS), a core component of brain motivation circuitry. However, it remains unclear to what extent this relationship holds for specific negative symptoms such as amotivation, and this question has not been addressed with integrated behavioral, clinical, and imaging measures. Here, 41 individuals with schizophrenia and 37 controls performed a brief, computerized progressive ratio task (PRT) that quantifies effort exerted in pursuit of monetary reward. Clinical amotivation was assessed using the recently validated Clinical Assessment Interview for Negative Symptoms (CAINS). VS function was probed during functional magnetic resonance imaging using a monetary guessing paradigm. We found that individuals with schizophrenia had diminished motivation as measured by the PRT, which significantly and selectively related to clinical amotivation as measured by the CAINS. Critically, lower PRT motivation in schizophrenia was also dimensionally related to VS hypofunction. Our results demonstrate robust dimensional associations between behavioral amotivation, clinical amotivation, and VS hypofunction in schizophrenia. Integrating behavioral measures such as the PRT will facilitate translational efforts to identify biomarkers of amotivation and to assess response to novel therapeutic interventions.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  fMRI; motivation; negative symptoms; progressive ratio; ventral striatum

Mesh:

Year:  2014        PMID: 24657876      PMCID: PMC4193711          DOI: 10.1093/schbul/sbu026

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  65 in total

1.  Tracking the hemodynamic responses to reward and punishment in the striatum.

Authors:  M R Delgado; L E Nystrom; C Fissell; D C Noll; J A Fiez
Journal:  J Neurophysiol       Date:  2000-12       Impact factor: 2.714

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  Puzzlingly High Correlations in fMRI Studies of Emotion, Personality, and Social Cognition.

Authors:  Edward Vul; Christine Harris; Piotr Winkielman; Harold Pashler
Journal:  Perspect Psychol Sci       Date:  2009-05

4.  Expected value and prediction error abnormalities in depression and schizophrenia.

Authors:  Victoria B Gradin; Poornima Kumar; Gordon Waiter; Trevor Ahearn; Catriona Stickle; Marteen Milders; Ian Reid; Jeremy Hall; J Douglas Steele
Journal:  Brain       Date:  2011-04-10       Impact factor: 13.501

5.  Neural correlates of probabilistic category learning in patients with schizophrenia.

Authors:  Thomas W Weickert; Terry E Goldberg; Joseph H Callicott; Qiang Chen; Jose A Apud; Sumitra Das; Brad J Zoltick; Michael F Egan; Martijn Meeter; Catherine Myers; Mark A Gluck; Daniel R Weinberger; Venkata S Mattay
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

6.  Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat.

Authors:  S Schmadel; K Schwabe; M Koch
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

Review 8.  Negative symptoms in schizophrenia: avolition and Occam's razor.

Authors:  George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

9.  Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Authors:  Henrik Walter; Hannes Kammerer; Karel Frasch; Manfred Spitzer; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2009-06-12       Impact factor: 4.530

10.  Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.

Authors:  Ryan D Ward; Eleanor H Simpson; Vanessa L Richards; Gita Deo; Kathleen Taylor; John I Glendinning; Eric R Kandel; Peter D Balsam
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

View more
  67 in total

Review 1.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.

Authors:  Michael Didriksen; Kim Fejgin; Simon R O Nilsson; Michelle R Birknow; Hannah M Grayton; Peter H Larsen; Jes B Lauridsen; Vibeke Nielsen; Pau Celada; Noemi Santana; Pekka Kallunki; Kenneth V Christensen; Thomas M Werge; Tine B Stensbøl; Jan Egebjerg; Francois Gastambide; Francesc Artigas; Jesper F Bastlund; Jacob Nielsen
Journal:  J Psychiatry Neurosci       Date:  2017-01       Impact factor: 6.186

3.  GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Authors:  Jared W Young; Mary E Kamenski; Kerin K Higa; Gregory A Light; Mark A Geyer; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

4.  Diminished effort on a progressive ratio task in both unipolar and bipolar depression.

Authors:  Rachel Hershenberg; Theodore D Satterthwaite; Aylin Daldal; Natalie Katchmar; Tyler M Moore; Joseph W Kable; Daniel H Wolf
Journal:  J Affect Disord       Date:  2016-02-16       Impact factor: 4.839

5.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

6.  Multisite Machine Learning Analysis Provides a Robust Structural Imaging Signature of Schizophrenia Detectable Across Diverse Patient Populations and Within Individuals.

Authors:  Martin Rozycki; Theodore D Satterthwaite; Nikolaos Koutsouleris; Guray Erus; Jimit Doshi; Daniel H Wolf; Yong Fan; Raquel E Gur; Ruben C Gur; Eva M Meisenzahl; Chuanjun Zhuo; Hong Yin; Hao Yan; Weihua Yue; Dai Zhang; Christos Davatzikos
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 7.  Effort cost computation in schizophrenia: a commentary on the recent literature.

Authors:  James M Gold; James A Waltz; Michael J Frank
Journal:  Biol Psychiatry       Date:  2015-05-11       Impact factor: 13.382

Review 8.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 9.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

10.  Common and Dissociable Dysfunction of the Reward System in Bipolar and Unipolar Depression.

Authors:  Theodore D Satterthwaite; Joseph W Kable; Lillie Vandekar; Natalie Katchmar; Danielle S Bassett; Claudia F Baldassano; Kosha Ruparel; Mark A Elliott; Yvette I Sheline; Ruben C Gur; Raquel E Gur; Christos Davatzikos; Ellen Leibenluft; Michael E Thase; Daniel H Wolf
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.